Figure S1 The entire region of module E (~5kb) was first dissected into 7 partially overlapping fragments (E1 to E7), the regulatory activity of which was then measured at 15h by qPCR, shown as histogram on bottom left. The region covering two active fragments E6 and E7 was again dissected into five smaller fragments (E-a to E-e) that also partially overlap by 500bp. QPCR measurement of the regulatory activity of these smaller constructs at 15h, shown on the bottom right, identified three active sequences: E-c, E-d, and E-e. The combined region of these three active sequences named EE was subjected to searching for even smaller sequence with comparable regulatory activity in B. (B) Progressive trimming from both ends of sequence EE was performed in order to search for the minimal region. QPCR measurement of the reporter activity driven by various the deletion forms of construct EE was performed at 15h and 21h and is shown in histograms. Fold change was calculated by comparing reporter expression driven by deleted constructs to that driven by the intact EE sequence. (C) Spatial expression of GFP transcripts in embryos injected with ME:gfp was analyzed by WMISH with GFP probe and scored in indicated number of embryos, showing similar pattern as that of the embryos injected with E:gfp (shown in Figure S1C ). Figure S1 The fusion construct D-ME:gfp is capable of driving endoderm-specific GFP expression. Foxa:rfp BAC was co-injected into embryos to label veg2 cells at 18h and veg2 endoderm at 24h. (C) Submodularization within module ME. Deletion series from both ends of ME discovered that the sequence encoded at the 5' end (ME5) and 3' end (ME3) drove distinct expressional profile of reporter activity. The histogram shows q-PCR measurement of reporter activity of various deletion constructs normalized to that of the wild-type ME construct. Spatial expression of GFP in the veg2 or veg1 lineage in embryos injected with ME5:gfp (D) and ME3:gfp (E) showing distinct spatial behavior: ME5:gfp is ubiquitous, and ME3:gfp is endoderm-restricted and exhibits similar spatial pattern as ME:gfp ( Figure S2C ). 
Figure S4 ME ME(ΔTCF1) ME(ΔTCF2) ME(ΔTCF1+2) ME(ΔHD site)
GFP expression fold change 15h 21h
Figure S5 Ets site Tcf site HD site Mutation ME ME(ΔTCF1) ME(ΔTCF2) ME ( QPCR measurement of the reporter activity driven by Tcf sites and/or Eve/Hox sites mutated ME:gfp constructs at 15h and 21h. (D-F) Whole mount in situ hybridization was performed to detect the localization of GFP transcripts in embryos injected with ME:gfp and Hox11/13b MASO or control MASO (D), wild-type ME:gfp (E), or Eve/Hox sites mutant ME:gfp (F). (D) Much higher percentage of embryos injected with ME:gfp showed GFP transcription in the anterior endoderm when co-injected with Hox11/13b MASO as compared to those co-injected with control MASO, examined at 30h. (E, F) Eve/Hox site mutation caused higher percentage (75% in F comparing to 40% for wildtype in E) of embryos with GFP expression in the anterior endoderm and lower percentage of embryos with expression in posterior endoderm at 30h. 
